ClinicalTrials.gov
public full text
Public Domain
A Study of IMC-1 In Patients With Fibromyalgia
This is a randomized, double-blind, placebo-controlled, 16-week study designed to evaluate the hypothesis that tissue-resident herpes virus may be causally related to fibromyalgia symptoms or recurrence. IMC-1 is a combination treatment that is designed to suppress this suspected virus and thus alleviate fibromyalgia symptoms.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effectiveness of Neural Therapy in Patients With Fibromiyalgia#992698
- High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza#883099
- Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases#1164029
- Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis#851101
- The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms#1124703
Record · ID 917839
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive